KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) Research & Development (2016 - 2025)

Historic Research & Development for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $52.0 million.

  • Xylem's Research & Development fell 545.45% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.0 million, marking a year-over-year decrease of 344.83%. This contributed to the annual value of $230.0 million for FY2024, which is 86.21% down from last year.
  • Xylem's Research & Development amounted to $52.0 million in Q3 2025, which was down 545.45% from $58.0 million recorded in Q2 2025.
  • Xylem's Research & Development's 5-year high stood at $61.0 million during Q3 2023, with a 5-year trough of $47.0 million in Q3 2022.
  • In the last 5 years, Xylem's Research & Development had a median value of $54.0 million in 2022 and averaged $54.6 million.
  • As far as peak fluctuations go, Xylem's Research & Development skyrocketed by 2978.72% in 2023, and later plummeted by 983.61% in 2024.
  • Over the past 5 years, Xylem's Research & Development (Quarter) stood at $52.0 million in 2021, then increased by 3.85% to $54.0 million in 2022, then increased by 11.11% to $60.0 million in 2023, then decreased by 3.33% to $58.0 million in 2024, then decreased by 10.34% to $52.0 million in 2025.
  • Its Research & Development stands at $52.0 million for Q3 2025, versus $58.0 million for Q2 2025 and $56.0 million for Q1 2025.